Vertex Pharmaceuticals
VRTX
VRTX
474 hedge funds and large institutions have $27.3B invested in Vertex Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 173 increasing their positions, 162 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
41% less call options, than puts
Call options by funds: $282M | Put options by funds: $481M
Holders
474
Holding in Top 10
5
Calls
$282M
Puts
$481M
Top Buyers
| 1 | +$217M | |
| 2 | +$115M | |
| 3 | +$90.8M | |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$75.6M |
| 5 |
HCM
Hoplite Capital Management
New York
|
+$72.1M |
Top Sellers
| 1 | -$445M | |
| 2 | -$317M | |
| 3 | -$206M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$149M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$125M |